Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma

Introduction Hepatosplenic T-cell lymphoma (HSTCL) is a rare peripheral T-cell lymphoma that disproportionately affects individuals with a clinical history of immunosuppression. It carries a poor prognosis, and, owing to its rarity, there is no single or well-established treatment. Patients and Methods We conducted the largest-to-date individual-level meta-analysis based on literature searches to determine the best induction therapy for HSTCL....